Crossmark

Improving the bioavailability of alendronate sodium using SBA-15 and SBA-16 for osteoporosis and its cytotoxic behavior towards osteosarcoma

Published Online: 2025-10-22

Authors

Patel, Anjali

Mehta, Shivangi
Funding

Funding for this research was provided by:

Education Department, Government of Gujarat, SHODH - ScHeme of Developing High Quality Research (2022017233)
License Information

Text and Data Mining valid from 2025-10-22

Version of Record valid from 2025-10-22
More Information

Article History

Received: 4 August 2025

Accepted: 12 October 2025

First Online: 22 October 2025

Declarations

:

: The authors declare no competing interests.

Document is current